Fresenius Kabi starts work on $250m US sterile drug plant

By Gareth Macdonald contact

- Last updated on GMT

Related tags: Manufacturing

Fresenius Kabi execs Steve Nowicki, Dr. Michael Schoenhofen and John Ducker join Mayor Ron Serpico of Melrose Park, Illinois at groundbreaking ceremony
Fresenius Kabi execs Steve Nowicki, Dr. Michael Schoenhofen and John Ducker join Mayor Ron Serpico of Melrose Park, Illinois at groundbreaking ceremony
Fresenius Kabi has started work on a $250m (€220m) sterile drug manufacturing plant in Illinois, US.

The German drug manufacturer announced plans for facility last year​, explaining that construction at the site in Chicago’s Melrose Park suburb will help it capture a greater share of the US injectables market.

The project will create several manufacturing suites equipped with automated aseptic filling lines, expanded lyophilization capabilities, and formulation areas, as well as a dedicated warehouse for raw materials.

Related news

Show more

Related products

show more

Shifting the Biomanufacturing Paradigm

Shifting the Biomanufacturing Paradigm

BioContinuum™ Platform - MilliporeSigma | 01-Jul-2020 | Technical / White Paper

Adoption of next generation processing and technologies can enable improvements in productivity by streamlining workflows, reducing the manufacturing plant...

Bio4C™ ProcessPad Software Datasheet

Bio4C™ ProcessPad Software Datasheet

BioContinuum™ Platform - MilliporeSigma | 01-Jul-2020 | Data Sheet

Biopharmaceutical processes are complex and highly variable in nature. This can result in inconsistent and sometimes unpredictable process outcomes. To...

Follow us

Products

View more

Webinars